Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Biotronik, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient is a candidate for implantation of a BIOTRONIK pacemaker system, per standard guidelines. Single chamber, dual chamber, and CRT-P systems are allowed.
Patient has an implant planned to utilize left bundle branch area (LBBA) pacing within 30 days of consent
Patient is able to understand the nature of the study and provide written informed consent
Patient is available for follow-up visits on a regular basis for the expected duration of follow-up
Patient accepts Home Monitoring® concept
Patient age is greater than or equal to 18 years at time of consent
You may not be if
Patient meets a standard contraindication for pacemaker system implant
Patient is currently implanted with a pacemaker or ICD device
Patient has had a previous unsuccessful attempt to place a lead in the LBBA
Patient has planned cardiac surgical procedures or interventional measures within 3 months after implant
Patient is expected to receive a heart transplant within 12 months
Patient life expectancy less than 12 months
Patient has the presence of another life-threatening, underlying illness separate from their cardiac disorder
Patient reports pregnancy at the time of enrollment
Patient is enrolled in any other investigational cardiac clinical study during the course of the study
Clareo Health | BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S
